{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 449584845
| IUPAC_name = (''RS'')-2-(4-imidazo[1,2-''a'']pyridin-2-ylphenyl)propanoic acid
| image = Miroprofen.svg
| width = 250px
| chirality = [[Racemic mixture]]
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 55843-86-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 68752
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 76249 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 61997
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = S00I5XG484

<!--Chemical data-->
| C=16 | H=14 | N=2 | O=2 
| molecular_weight = 266.295 g/mol
| smiles = O=C(O)C(c3ccc(c1nc2ccccn2c1)cc3)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H14N2O2/c1-11(16(19)20)12-5-7-13(8-6-12)14-10-18-9-3-2-4-15(18)17-14/h2-11H,1H3,(H,19,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OJGQFYYLKNCIJD-UHFFFAOYSA-N
| synonyms = Antopen; BRN 0888858; NSC 261037; Ro 07-0582; Y 9213; <small>2-[4-(1,7-diazabicyclo[4.3.0]nona-2,4,6,8-tetraen-8-yl)phenyl]propanoic acid</small>
}}

'''Miroprofen''' ([[International Nonproprietary Name|INN]]) is an [[analgesic]] and [[Non-steroidal anti-inflammatory drug|NSAID]], meaning that it has [[anti-inflammatory]], [[antipyretic]] and [[Antiplatelet drug|antiplatelet aggregation]] activity. Chemically it is a [[carbocycle|carbocyclic]] acid and a [[phenylpropionate]].<ref name="Mikashima-1982">{{Cite journal  | last1 = Mikashima | first1 = H. | last2 = Goto | first2 = K. | title = [Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)] | journal = Yakugaku Zasshi | volume = 102 | issue = 1 | pages = 99â€“103 |date=Jan 1982 | doi =  | pmid = 7045328 }}</ref>

==References==
<references/>

{{NSAIDs}}
{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Imidazopyridines]]


{{musculoskeletal-drug-stub}}